Treatment of Severe Atrophy with Juxta-Osseous Implants: A Systematic Review and Case Report
Bioengineering · 27.03.2026 · 13 (4) · 386
DOI: 10.3390/bioengineering13040386 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 27.03.2026. Verfasst von Alberto Gasbarri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: B&B Dental S.r.l., B&B Dental.
Abstract (Originalsprache)
Background
Severe jaw atrophy limits traditional endosseous implantation, often necessitating complex regenerative procedures. Advances in digital planning and 3D printing have reintroduced custom-made subperiosteal (juxta-osseous) implants as a viable alternative. This study evaluates the clinical reliability and advantages of next-generation juxta-osseous implants. Materials and Methods: A systematic review was conducted in accordance with PRISMA guidelines across the PubMed, Scopus, and Web of Science databases. The search focused on English-language studies reporting on custom-made titanium juxta-osseous implants in patients with severe maxillary or mandibular atrophy. Methodological quality was assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist. Additionally, a representative clinical case of a 60-year-old female treated via a fully digital workflow is presented to illustrate the protocol.
Results
Twenty-six articles were included, accounting for 147 clinical cases. Most patients exhibited Cawood and Howell Class V–VI atrophy. All identified treatments utilized integrated digital workflows, including CBCT imaging, CAD/CAM design, and additive manufacturing (SLM/DMLS) of medical-grade titanium alloy. Reported success rates exceeded 90%, with high primary stability enabling immediate or early loading protocols and high patient satisfaction. Complications were primarily limited to manageable soft-tissue dehiscence.
Conclusions
Modern juxta-osseous implants represent a promising, minimally invasive alternative to bone grafting for severe atrophy, enabling rapid functional restoration in the short-to-medium-term. However, because current evidence is limited to clinical studies, these findings should be interpreted with caution. Long-term prospective trials are essential to establish definitive clinical predictability and standardized protocols.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
- Department of Maxillo-Facial Surgery, San Salvatore Hospital, ASL1 Abruzzo, Coppito, 67100 L'Aquila, Italy.
ORCID-Profile: Maurizio D'Amario
Förderung
- B&B Dental S.r.l.
- B&B Dental
Zitieren
APA
Gasbarri, A., Giovannetti, F., Caporro, G., D'Amario, M., Sperati, R., Jahjah, A., Lupi, E., & Capogreco, M. (2026). Treatment of Severe Atrophy with Juxta-Osseous Implants: A Systematic Review and Case Report. Bioengineering, 13(4), 386. https://doi.org/10.3390/bioengineering13040386
Vancouver
Gasbarri A, Giovannetti F, Caporro G, D'Amario M, Sperati R, Jahjah A, et al. Treatment of Severe Atrophy with Juxta-Osseous Implants: A Systematic Review and Case Report. Bioengineering. 2026;13(4):386. doi:10.3390/bioengineering13040386
BibTeX
@article{Gasbarri2026,
author = {Gasbarri, Alberto and Giovannetti, Filippo and Caporro, Giulia and D'Amario, Maurizio and Sperati, Renato and Jahjah, Ali and Lupi, Ettore and Capogreco, Mario},
title = {Treatment of Severe Atrophy with Juxta-Osseous Implants: A Systematic Review and Case Report},
journal = {Bioengineering},
year = {2026},
volume = {13},
number = {4},
pages = {386},
doi = {10.3390/bioengineering13040386}
}
EUVIMED